Semler Scientific, Inc. (NASDAQ:SMLR) Q4 2024 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The company's earnings call presents mixed signals. While there are strong positives like record cash generation, significant Bitcoin holdings, and EPS exceeding expectations, there are also concerns. The absence of a shareholder return plan, potential regulatory risks, and market risks associated with Bitcoin introduce uncertainties. Moreover, management's lack of clarity on 2025 expectations and the reliance on Bitcoin performance pose potential downsides. The convertible note offering and market capitalization growth are positive, but the overall sentiment remains neutral due to the balance of risks and opportunities.
Key Financial Performance
Earnings Per Share (EPS) $3.41, an increase from expectations of $0.26.
Bitcoin Holdings 3,192 bitcoins valued at more than $300 million, representing a substantial increase since adopting Bitcoin as a treasury reserve asset.
Bitcoin Yield 152% positive yield since adopting Bitcoin treasury strategy.
Market Capitalization Increased by more than 200% since adopting Bitcoin treasury strategy.
Cash Generation from Health Care Operations Over $24 million in 2024, indicating strong performance in cash generation.
Proceeds from Minority Investment $3.5 million from monetizing a portion of the investment in Monarch Medical, used to purchase more Bitcoin.
Convertible Senior Notes Offering $100 million raised, contributing to Bitcoin purchases.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
510(k) Clearance: Seeking a new 510(k) clearance for a product extension of QuantaFlo technology.
Bitcoin Treasury Strategy: Adopted Bitcoin as primary treasury reserve asset, now holding 3,192 bitcoins valued at over $300 million.
Market Capitalization Growth: Market capitalization has grown by more than 200% since adopting Bitcoin treasury strategy.
Cash Generation: Achieved record cash generation of over $24 million in 2024.
Investment Strategy: Utilized operating cash flow and proceeds from offerings to accumulate Bitcoin.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Regulatory Risks: The company is seeking a new 510(k) clearance for a product extension of its QuantaFlo technology, which involves regulatory approval processes that could pose risks to timely market entry.
Market Risks: The adoption of Bitcoin as a primary treasury reserve asset introduces volatility and market risks associated with cryptocurrency fluctuations.
Supply Chain Challenges: The company has made substantial purchases of Bitcoin, which may impact liquidity and financial flexibility, especially if market conditions change.
Economic Factors: The company's financial performance is tied to its healthcare operations, which may be affected by broader economic conditions and healthcare market dynamics.
Investment Risks: The strategy of accumulating Bitcoin and reliance on its performance could expose the company to significant financial risks if Bitcoin's value declines.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Bitcoin Treasury Strategy: Adopted Bitcoin as primary treasury reserve asset in May 2024, becoming the second U.S. public company to do so. Currently own 3,192 bitcoins valued at over $300 million, with a positive bitcoin yield of 152% since adoption.
Market Capitalization Growth: Market capitalization has grown by more than 200% since adopting Bitcoin treasury strategy.
510(k) Clearance: Seeking new 510(k) clearance for a product extension of QuantaFlo technology.
Revenue Opportunities: Pursuing additional revenue opportunities in the cardiovascular space.
Cash Generation: Achieved record cash generation of over $24 million in 2024.
Future Acquisitions: Plans to acquire additional Bitcoin using operating cash flow and proceeds from offerings.
Convertible Senior Notes Offering: Raised $100 million through a convertible senior notes offering.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Shareholder Return Plan: Semler Scientific has not discussed any specific shareholder return plan, such as a shares buyback program or dividend program, during the earnings call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Why did you decide to do the convertible note offering?
A:We decided to raise capital in the convert market because we believe it is a cheaper source of funding for us and that’s less dilutive to our stockholders and because it gave us the opportunity to raise a large amount of capital in a very short amount of time.
Q:What’s driving the underlying trends in the business? And what do you expect for 2025?
A:Despite the government decision about payment for risk adjustment for PAD, we continue to add new clients for software licenses relating to our QuantaFlo product. Our priority for 2025 is to minimize the declines to QuantaFlo revenue while maintaining sufficient infrastructure to support, innovate and grow our operations related to other cardiovascular diseases.
Q:What are your expectations from the new government in Washington, D.C. regarding crypto?
A:We are excited about the strong government support Bitcoin is finally getting. We are especially encouraged by the repeal of SAB 121 and the opportunity that creates for major banks to custody Bitcoin.
Q:Review of Unclear Management Responses
A:Management did not provide a clear answer regarding expectations for 2025, particularly in terms of specific revenue projections or strategies to counteract potential declines.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
ATM purchase
Chairman update
Conference participant
Dr Chutorian
Full Financial
Harbor provision
Inc expectation
Instructions event
Investor Relations
Private Securities
QuantaFlo treasury
Relations page
Safe Harbor
Scientific Full
Scientific need
Scientific sir
Semler Chairman
Transcript Semler
care cash
cash proceeds
expectation afternoon
generation health
meaning Safe
mode Instructions
need comment
participant mode
proceeds ATM
purchase Semler
result cash
sir afternoon
today press
treasury statement
update Treasury
website Dr
SMLR Transcript
Semler Scientific, Inc. (SMLR) Q2 2025 Earnings Call Transcript
Unknown8-4
The earnings call reveals several concerns: declining revenue and operating losses in the healthcare segment, significant risk from heavy Bitcoin investments, legal expenses from a DOJ settlement, and reliance on equity issuance, which could dilute shareholder value. While there is a positive Bitcoin yield, the volatility and risks associated with Bitcoin, combined with a weak healthcare business performance, outweigh the positives. The Q&A session did not alleviate these concerns, as management's optimism about Bitcoin adoption does not mitigate the financial and operational risks. Overall, these factors suggest a negative stock price reaction.
Semler Scientific, Inc. (NASDAQ:SMLR) Q1 2025 Earnings Call Transcript
Unknown5-14
The earnings call highlights a strong focus on Bitcoin acquisitions, which exposes the company to volatility and regulatory risks. Despite cash generation and Bitcoin gains, the healthcare business faces challenges and lacks clear growth guidance. The $500 million ATM program and convertible notes increase financial leverage. The Q&A session reveals concerns about unclear management responses and potential declines in healthcare revenue. These factors, along with the economic and competitive pressures, suggest a negative sentiment, likely resulting in a stock price decline of -2% to -8%.
Semler Scientific, Inc. (SMLR) Q1 2025 Earnings Call Transcript
Unknown5-13
The earnings call highlights significant financial struggles, including a 44% revenue decline, operational losses, and liquidity concerns. Despite ambitious Bitcoin acquisition plans, the volatility poses financial risks. Regulatory issues add uncertainty, and the management's vague future outlook further exacerbates investor concerns. The overall sentiment is strongly negative, with potential stock decline exceeding -8%.
Semler Scientific, Inc. (NASDAQ:SMLR) Q4 2024 Earnings Call Transcript
Unknown2-19
The company's earnings call presents mixed signals. While there are strong positives like record cash generation, significant Bitcoin holdings, and EPS exceeding expectations, there are also concerns. The absence of a shareholder return plan, potential regulatory risks, and market risks associated with Bitcoin introduce uncertainties. Moreover, management's lack of clarity on 2025 expectations and the reliance on Bitcoin performance pose potential downsides. The convertible note offering and market capitalization growth are positive, but the overall sentiment remains neutral due to the balance of risks and opportunities.
SMLR Slides
SMLR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
